Legorreta Pablo G.
- SEC CIK
- 0001507678
No open-market purchases or sales filed in the past year.
Current role at each company
- RPRX Royalty Pharma plcCEO, Chairman of the Boardas of Aug 7, 2026
- PROK Prokidney Corp.Director, 10% Owneras of May 29, 2026
- EPZM Epizyme, Inc.Director, 10% Owneras of Aug 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Legorreta Pablo G. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PROK Prokidney Corp.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 (view filing)4:05 PM ET | Jun 13 | 1 day | Legorreta Pablo G. and 1 otherDirector, 10% Owner | PPurchaseClass A Ordinary Shares | +22.6M | $2.42 | +$54.7M | New position22.6M after |
RPRX Royalty Pharma plc
CEO, Chairman of the Board4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 (view filing) | May 16-17 | 1 day | Legorreta Pablo G.CEO, Chairman of the Board | PPurchaseClass A ordinary shares | +230.0K | $33.38 | +$7.68M | New position230.0K after | 2 lots |
| May 24, 2023 (view filing) | May 24 | Same day | Legorreta Pablo G.CEO, Chairman of the Board | PPurchaseClass A ordinary shares | +150.0K | $32.25 | +$4.84M | +65.2%380.0K after | |
| Jun 13, 2023 (view filing) | Jun 12-13 | 1 day | Legorreta Pablo G.CEO, Chairman of the Board | PPurchaseClass A ordinary shares | +90.0K | $32.89 | +$2.96M | +23.7%470.0K after | 2 lots |
| Jun 28, 2023 (view filing) | Jun 28 | Same day | Legorreta Pablo G.CEO, Chairman of the Board | PPurchaseClass A ordinary shares | +130.0K | $29.51 | +$3.84M | +27.7%600.0K after |
EPZM Epizyme, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 (view filing)4:17 PM ET | Jan 31 | 1 day | Legorreta Pablo G. and 2 othersDirector, 10% Owner | PPurchase | +22.7M | $1.50 | +$34.0M | +247.3%31.8M after |